Insiders · Profile

RAMSAY DAVID A

Director at Savara · VP and Chief Financial Officer at HALOZYME THERAPEUTICS. Filing since 14 May 2007. CIK 0001283292

Company
Date
Role
Action
Shares
Amount
Of holding
19 Dec 2025
Director
Sold at will
20,000
$121.22K
0.8%
31 Mar 2025
Director
Bought
150,000
$416.25K
6.3%
18 Nov 2024
Director
Bought
100,000
$287.60K
4.5%
26 May 2023
Director
Bought
37,124
$97.60K
1.7%
25 May 2023
Director
Bought
12,876
$33.13K
0.6%
24 May 2023
Director
Bought
50,000
$127.80K
2.4%
30 Dec 2022
Director
Bought
29,000
$44.83K
1.4%
29 Dec 2022
Director
Bought
7,000
$10.75K
0.3%
28 Dec 2022
Director
Bought
3,293
$4.92K
0.2%
23 Dec 2022
Director
Bought
15,707
$22.67K
0.8%
22 Dec 2022
Director
Bought
41,414
$61.13K
2.1%
20 Dec 2022
Director
Bought
17,416
$26.07K
0.9%
19 Dec 2022
Director
Bought
40,719
$60.83K
2.1%
16 Dec 2022
Director
Bought
341
$511.50
0.0%
23 Nov 2022
Director
Bought
4,610
$6.63K
0.2%
22 Nov 2022
Director
Bought
15,495
$22.02K
0.8%
21 Nov 2022
Director
Bought
25,005
$35.53K
1.3%
18 Nov 2022
Director
Bought
16,100
$21.61K
0.9%
17 Nov 2022
Director
Bought
8,900
$11.30K
0.5%
27 Sep 2022
Director
Bought
73,893
$101.38K
4.1%
26 Sep 2022
Director
Bought
31,107
$43.05K
1.8%
23 Sep 2022
Director
Bought
30,000
$42.66K
1.7%
20 Sep 2022
Director
Bought
600
$870.00
0.0%
19 Sep 2022
Director
Bought
1,400
$2.04K
0.1%
16 Sep 2022
Director
Bought
6,000
$8.65K
0.3%
8 Sep 2022
Director
Bought
29,000
$40.57K
1.7%
7 Sep 2022
Director
Bought
2,130
$2.95K
0.1%
6 Sep 2022
Director
Bought
870
$1.20K
0.1%
1 Sep 2022
Director
Bought
39,768
$56.47K
2.4%
31 Aug 2022
Director
Bought
39,494
$56.20K
2.4%
30 Aug 2022
Director
Bought
20,738
$29.26K
1.3%
22 Jun 2022
Director
Bought
39,000
$56.36K
2.5%
21 Jun 2022
Director
Bought
21,094
$29.11K
1.4%
17 Jun 2022
Director
Bought
39,906
$52.92K
2.7%
30 Dec 2021
Director
Bought
35,000
$45.36K
2.4%
29 Dec 2021
Director
Bought
15,000
$18.68K
1.0%
17 Dec 2021
Director
Bought
25,000
$28.23K
1.8%
15 Dec 2021
Director
Bought
15,000
$16.26K
1.1%
10 Dec 2021
Director
Bought
35,000
$36.37K
2.5%
8 Dec 2021
Director
Bought
13,157
$13.81K
1.0%
7 Dec 2021
Director
Bought
11,843
$12.40K
0.9%
2 Dec 2021
Director
Bought
21,394
$23.23K
1.6%
1 Dec 2021
Director
Bought
12,606
$13.66K
1.0%
30 Nov 2021
Director
Bought
16,000
$17.39K
1.2%
22 Nov 2021
Director
Bought
90,000
$97.02K
7.4%
19 Nov 2021
Director
Bought
49,800
$53.24K
4.3%
18 Nov 2021
Director
Bought
60,200
$65.14K
5.5%
30 Sep 2021
Director
Bought
50,000
$64.90K
4.8%
29 Sep 2021
Director
Bought
47,500
$60.66K
4.7%
28 Sep 2021
Director
Bought
39,552
$50.82K
4.1%
18 Aug 2021
Director
Bought
30,736
$36.98K
3.3%
17 Aug 2021
Director
Bought
66,554
$78.20K
7.7%
19 May 2021
Director
Bought
5,003
$7.90K
0.6%
18 May 2021
Director
Bought
50,000
$81.10K
6.2%
15 Mar 2021
Director
Bought
689,655
$1,000.00K
565%
28 Jun 2019
Director
Bought
35,157
$82.31K
40.4%
27 Jun 2019
Director
Bought
22,300
$53.77K
34.5%
26 Jun 2019
Director
Bought
900
$2.14K
1.4%
18 Jun 2019
Director
Bought
15,215
$35.81K
31.3%
17 Jun 2019
Director
Bought
25,000
$59.55K
106%
7 Jun 2017
Director
Bought
21,000
$99.75K
×15
16 Sep 2014
VP and Chief Financial Officer
Bought
25,000
$222.50K
8.4%
14 May 2012
Director
Bought
50,000
$26.97K
100%
10 May 2012
Director
Bought
40,000
$22.61K
400%
9 May 2012
Director
Bought
10,000
$5.50K
opened
18 Mar 2008
Secretary, CFO
Bought
10,000
$45.57K
2.5%
16 Jul 2007
Secretary, CFO
Sold, plan not stated
10,000
$98.90K
2.6%
14 Jun 2007
Secretary, CFO
Sold, plan not stated
10,000
$101.04K
2.6%
14 May 2007
Secretary, CFO
Sold, plan not stated
10,000
$101.90K
2.5%
69 decisions on file.